Trial
NCT02369796
A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Hypogonadotropic Hypogonadism
Intervention
TAK-448
Why stopped
Sponsor decision to terminate the study because the study did not achieve the primary efficacy objective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-31